Front Page-Rx

Delaware’s state Legislature has established the Interagency Pharmaceuticals Purchasing Study Group to recommend steps to leverage bulk purchasing of drugs to effectively negotiate lower prices by using interagency and multistate purchasing contracts, and other approaches. The measure easily passed the House on a voice vote and unanimously passed the Senate. The study group has an […]

Read More
  • State Health Policy Blog

    NASHP Updates Model Drug Price Transparency Legislation, Featuring a Common Data Set for Cross-State Comparisons and Stronger Enforcement

    As drug price transparency measures proliferate across states, the National Academy of State Health Policy (NASHP) has released revised model transparency legislation featuring a common data set to reduce reporter burden and yield standardized, actionable data that will be comparable across states.  The data — to be reported by manufacturers, pharmacy benefit managers (PBMs), wholesalers, and insurers — will […]

    Read More
    April 23, 2019 | Filed under: Front Page, Front Page-Rx, Maine, State Health Policy Blog

  • State Health Policy Blog

    New Law Enables New Mexico to Leverage State Purchasing Power to Lower Rx Spending

    New Mexico Gov. Lujan Grisham recently signed into law SB 131, establishing a state Interagency Pharmacy Purchasing Council to leverage public purchasing power by reviewing and coordinating cost-containment strategies through procurement of pharmaceuticals, pharmaceutical benefits, and pooling of risk among state agencies. Cosponsored by state Sen. Jeff Steinborn* and Rep. Joanne Farrary, the law also […]

    Read More
  • Publications

    State Initiatives Using Purchasing Power to Achieve Drug Cost Containment

    This report focuses on several state purchasing strategies designed to achieve concessions in negotiations with drug manufacturers and in other parts of the prescription drug supply chain. The highlighted strategies include intrastate actions, which combine state agencies’ purchases of drugs to improve their negotiating clout, and interstate activities, such as multi-state organizations that unite to […]

    Read More
    April 15, 2019 | Filed under: Featured-Rx, Front Page-Rx, Medicaid, Payment Reform, Publications

  • Publications

    Cross-Agency Strategies to Curb Health Care Costs: Leveraging State Purchasing Power

    Rising health care costs are an intractable problem in the United States, but states, faced with balanced budget requirements and growing voter concern, aren’t waiting for a federal solution. This report explores state initiatives to curb health care costs by:  Leveraging Medicare’s well-established reimbursement rates as reference prices for state employee plans to address rising […]

    Read More
  • State Health Policy Blog

    Montana Explores a New Approach to Regulating Pharmacy Benefit Managers

    State legislatures across the country continue efforts to address the opaque business practices of pharmacy benefit managers (PBMs) to protect consumers and lower prescription drug prices. Montana is taking a new approach by leveraging its insurance department’s regulatory authority over insurance carriers by proposing a bill that tasks insurers with responsibility for overseeing that PBMs […]

    Read More
  • State Health Policy Blog

    Annual Federal Insurance Rule Includes Proposals to Address Prescription Drug Cost

    The Trump Administration’s effort to address drug prices surfaced unexpectedly in the Department of Health and Human Services (HHS)’s recently issued proposed annual rule that regulates state health insurance markets, including coverage sold through the Affordable Care Act (ACA) marketplaces. The proposal encourages the use of generic drugs over brand-name drugs by both health plans and enrollees […]

    Read More
  • State Health Policy Blog
    New Tools Help States Document Rx Costs and Identify Potential Savings

    New Tools Help States Document Rx Costs and Identify Potential Savings

    Just how much are states spending on prescription drugs? And, which drugs account for their greatest expense? As state policymakers grapple with solutions to the problem of rising drug costs, officials are performing research to  provide critical evidence and tools needed to inform policy. Two recent state efforts to document their prescription drug costs may […]

    Read More
  • State Health Policy Blog
    As State Legislatures Convene, Lawmakers Quickly Submit Bills to Curb Prescription Prices

    As State Legislatures Convene, Lawmakers Quickly Submit Bills to Curb Prescription Prices

    One week into the 2019 legislative season, lawmakers from 11 states have already submitted 30 bills to address the rising cost of prescription drugs. The bills submitted to date seek to implement wholesale drug importation programs, increase pharmaceutical pricing transparency, and regulate pharmacy benefit managers (PBMs), along with other drug cost containment initiatives. Last year, […]

    Read More
  • Maps
    State Legislative Action to Lower Pharmaceutical Costs

    State Legislative Action to Lower Pharmaceutical Costs

    Updated May 16, 2019* Find the status of state legislation to address prescription drug costs below. Use the category button to search by type of legislation and roll over a state to view its pending drug legislation. Download or view a chart listing 2019 legislation by state. View state action in 2018, 2017, and 2015-2016. Email information about new bills or legislative action to Sarah Lanford. This map […]

    Read More
    January 7, 2019 | Filed under: Featured, Featured-Rx, Front Page-Rx, Maps, Rx Featured New